Molecular and cellular mechanisms of photocarcinogenesis

Photochemistry and Photobiology

Volumn 84, Issue 1, 2008, Pages 29-34

  Beissert, Stefan ^a   Loser, Karin ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN; UROCANIC ACID;

ANIMAL; CARCINOMA; CONFERENCE PAPER; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; PATHOLOGY; RADIATION EXPOSURE; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

ANIMALS; ANTIGENS, CD; CARCINOMA; HUMANS; IMMUNE SYSTEM; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS; UROCANIC ACID;

MUS;

EID: 37249088408     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1751-1097.2007.00231.x     Document Type: Conference Paper

References (56)

1. Howe, H. L., P. A. Wingo, M. J. Thun, L. A. Ries, H. M. Rosenberg, E. G. Feigal B. K. Edwards (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl Cancer Inst. 93, 824 842.
2. Slaper, H., G. J. Velders, J. S. Daniel, F. R. de Gruijl J. C. van der Leun (1996) Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements. Nature 384, 256 258.
3. Urbach, F. (1997) Ultraviolet radiation and skin cancer of humans. J. Photochem. Photobiol. B, Biol. 40, 3 7.
4. Setlow, R. B., E. Grist, K. Thompson A. D. Woodhead (1993) Wavelengths effective in induction of malignant melanoma. Proc. Natl Acad. Sci. USA 90, 6666 6670.
5. Urbach, F. (1991) Potential health effects of climatic change: Effects of increased ultraviolet radiation on man. Environ. Health Perspect. 96, 175 176.
6. van der Leun, J. C., F. R. de Gruijl, M. Tevini R. C. Worrest (1993) Ultraviolet carcinogenesis: Environmental effects of ozone depletion. Recent Results Cancer Res. 128, 263 267.
7. Boyle, J., R. M. MacKie, J. D. Briggs, B. J. Junor T. C. Aitchison (1984) Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1, 702 705.
8. Marshall, V. (1974) Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation 17, 272 275.
9. O'Donovan, P., C. M. Perrett, X. Zhang, B. Montaner, Y. Z. Xu, C. A. Harwood, J. M. McGregor, S. L. Walker, F. Hanaoka P. Karran (2005) Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309, 1871 1874.
10. Norbury, K. C. M. L. Kripke (1978) Ultraviolet carcinogenesis in T-cell-depleted mice. J. Natl Cancer Inst. 61, 917 921.
11. Kripke, M. L. (1974) Antigenicity of murine skin tumors induced by ultraviolet light. J. Natl Cancer Inst. 53, 1333 1336.
12. Kripke, M. L. (1977) Ultraviolet radiation and tumor immunity. J. Reticuloendothel. Soc. 22, 217 222.
13. Kripke, M. L. (1977) Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. Cancer Res. 37, 1395 1400.
14. Kripke, M. L. M. S. Fisher (1976) Immunologic responses of the autochthonous host against tumors induced by ultraviolet light. Adv. Exp. Med. Biol. 66, 445 449.
15. Kripke, M. L. M. S. Fisher (1978) Immunologic aspects of tumor induction by ultraviolet radiation. Natl. Cancer Inst. Monogr. 50, 179 183.
16. Kripke, M. L., R. M. Thorn, P. H. Lill, C. I. Civin, N. H. Pazmino M. S. Fisher (1979) Further characterization of immunological unresponsiveness induced in mice by ultraviolet radiation. Growth and induction of nonultraviolet- induced tumors in ultraviolet-irradiated mice. Transplantation 28, 212 217.
17. Fisher, M. S. M. L. Kripke (1978) Further studies on the tumor-specific suppressor cells induced by ultraviolet radiation. J. Immunol. 121, 1139 1144.
18. Fisher, M. S. M. L. Kripke (1982) Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216, 1133 1134.
19. Simon, J. C., H. Hara, R. W. Denfeld S. Martin (2002) UVB-irradiated dendritic cells induce nonproliferating, regulatory type T cells. Skin Pharmacol. Appl. Skin Physiol. 15, 330 334.
20. Schroder, J. M., K. Reich, K. Kabashima, F. T. Liu, N. Romani, M. Metz, A. Kerstan, P. H. Lee, K. Loser, M. P. Schon, M. Maurer, P. Stoitzner, S. Beissert, Y. Tokura R. L. Gallo (2006) Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 15, 913 929.
21. Beissert, S. R. D. Granstein (1996) UV-induced cutaneous photobiology. Crit. Rev. Biochem. Mol. Biol. 31, 381 404.
22. Grabbe, S., S. Bruvers, R. L. Gallo, T. L. Knisely, R. Nazareno R. D. Granstein (1991) Tumor antigen presentation by murine epidermal cells. J. Immunol. 146, 3656 3661.
23. Grabbe, S., S. Bruvers, A. M. Lindgren, J. Hosoi, K. C. Tan R. D. Granstein (1992) Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: Modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation. J. Leukoc. Biol. 52, 209 217.
24. Hodge, J. W., S. Abrams, J. Schlom J. A. Kantor (1994) Induction of antitumor immunity by recombinant vaccinia viruses expressing B7-1 or B7-2 costimulatory molecules. Cancer Res. 54, 5552 5555.
25. Lenschow, D. J., T. L. Walunas J. A. Bluestone (1996) CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233 258.
26. Tang, A., T. A. Judge, B. J. Nickoloff L. A. Turka (1996) Suppression of murine allergic contact dermatitis by CTLA4Ig. Tolerance induction of Th2 responses requires additional blockade of CD40-ligand. J. Immunol. 157, 117 125.
27. Krummel, M. F. J. P. Allison (1995) CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182, 459 465.
28. Kuchroo, V. K., M. P. Das, J. A. Brown, A. M. Ranger, S. S. Zamvil, R. A. Sobel, H. L. Weiner, N. Nabavi L. H. Glimcher (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707 718.
29. Thompson, C. B. (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979 982.
30. Boussiotis, V. A., J. G. Gribben, G. J. Freeman L. M. Nadler (1994) Blockade of the CD28 co-stimulatory pathway: A means to induce tolerance. Curr. Opin. Immunol. 6, 797 807.
31. Beissert, S., J. A. Bluestone, I. Mindt, M. Voskort, D. Metze, A. Mehling, T. A. Luger, T. Schwarz S. Grabbe (1999) Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation. J. Immunol. 163, 6725 6731.
32. Loser, K., A. Scherer, M. B. Krummen, G. Varga, T. Higuchi, T. Schwarz, A. H. Sharpe, S. Grabbe, J. A. Bluestone S. Beissert (2005) An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice. J. Immunol. 174, 5298 5305.
33. Kim, J., R. L. Modlin, R. L. Moy, S. M. Dubinett, T. McHugh, B. J. Nickoloff K. Uyemura (1995) IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J. Immunol. 155, 2240 2247.
34. Dummer, W., B. C. Bastian, N. Ernst, C. Schanzle, A. Schwaaf E. B. Brocker (1996) Interleukin-10 production in malignant melanoma: Preferential detection of IL-10-secreting tumor cells in metastatic lesions. Int. J. Cancer 66, 607 610.
35. Dummer, W., J. C. Becker, A. Schwaaf, M. Leverkus, T. Moll E. B. Brocker (1995) Elevated serum levels of interleukin-10 in patients with metastatic malignant melanoma. Melanoma Res. 5, 67 68.
36. Kruger-Krasagakes, S., K. Krasagakis, C. Garbe, E. Schmitt, C. Huls, T. Blankenstein T. Diamantstein (1994) Expression of interleukin 10 in human melanoma. Br. J. Cancer 70, 1182 1185.
37. Richter, G., S. Kruger-Krasagakes, G. Hein, C. Huls, E. Schmitt, T. Diamantstein T. Blankenstein (1993) Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration. Cancer Res. 53, 4134 4137.
38. Ding, W., S. Beissert, L. Deng, E. Miranda, C. Cassetty, K. Seiffert, K. L. Campton, Z. Yan, G. F. Murphy, J. A. Bluestone R. D. Granstein (2003) Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis. J. Clin. Invest. 111, 1923 1931.
39. Loser, K., J. Apelt, M. Voskort, M. Mohaupt, S. Balkow, T. Schwarz, S. Grabbe S. Beissert (2007) IL-10 controls ultraviolet-induced carcinogenesis in mice. J. Immunol. 179, 365 371.
40. Loser, K., W. Hansen, J. Apelt, S. Balkow, J. Buer S. Beissert (2005) In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther. 12, 1294 1304.
41. Ziegler, S. F. (2006) FOXP3: Of mice and men. Annu. Rev. Immunol. 24, 209 226.
42. Nishigori, C., D. B. Yarosh, S. E. Ullrich, A. A. Vink, C. D. Bucana, L. Roza M. L. Kripke (1996) Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. Proc. Natl Acad. Sci. USA 93, 10354 10359.
43. Mohammad, T., H. Morrison H. HogenEsch (1999) Urocanic acid photochemistry and photobiology. Photochem. Photobiol. 69, 115 135.
44. Reeve, V. E., G. E. Greenoak, P. J. Canfield, C. Boehm-Wilcox C. H. Gallagher (1989) Topical urocanic acid enhances UV-induced tumour yield and malignancy in the hairless mouse. Photochem. Photobiol. 49, 459 464.
45. Beissert, S., T. Mohammad, H. Torri, A. Lonati, Z. Yan, H. Morrison R. D. Granstein (1997) Regulation of tumor antigen presentation by urocanic acid. J. Immunol. 159, 92 96.
46. Beissert, S., D. Ruhlemann, T. Mohammad, S. Grabbe, A. El-Ghorr, M. Norval, H. Morrison, R. D. Granstein T. Schwarz (2001) IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: Implications for photocarcinogenesis. J. Immunol. 167, 6232 6238.
47. Willimsky, G. T. Blankenstein (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437, 141 146.
48. Thien, C. B. W. Y. Langdon (2001) Cbl: Many adaptations to regulate protein tyrosine kinases. Nat. Rev. Mol. Cell Biol. 2, 294 307.
49. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y. Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, J. Le, P. S. Ohashi, I. Sarosi, H. Nishina, S. Lipkowitz J. M. Penninger (2000) Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211 216.
50. Chiang, Y. J., H. K. Kole, K. Brown, M. Naramura, S. Fukuhara, R. J. Hu, I. K. Jang, J. S. Gutkind, E. Shevach H. Gu (2000) Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216 220.
51. - mice. J. Immunol. 173, 1059 1065.
52. Chiang, J. Y., I. K. Jang, R. Hodes H. Gu (2007) Ablation of Cbl-b provides protection against transplanted and spontaneous tumors. J. Clin. Invest. 117, 1029 1036.
53. + T cells. J. Exp. Med. 204, 879 891.
54. Beissert, S. T. Schwarz (1999) Mechanisms involved in ultraviolet light-induced immunosuppression. J. Investig. Dermatol. Symp. Proc. 4, 61 64.
55. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger S. Beissert (2006) Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12, 1372 1379.
56. Jones, D. H., T. Nakashima, O. H. Sanchez, I. Kozieradzki, S. V. Komarova, I. Sarosi, S. Morony, E. Rubin, R. Sarao, C. V. Hojilla, V. Komnenovic, Y. Y. Kong, M. Schreiber, S. J. Dixon, S. M. Sims, R. Khokha, T. Wada J. M. Penninger (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440, 692 696.